Vancouver Coastal Health Research Institute
Media Release | February 21, 2014
UBC researchers have developed a technique that targets proteins that cause disease and destroys “bad apples” in the cell.
Media Release | February 17, 2014
UBC researchers have found how the devastating disease ALS, also known as Lou Gehrig’s disease, spreads — and say transmission can be blocked.
Media Release | May 14, 2013
Forget apples – lifting weights and doing cardio can also keep the doctors away, according a new study by researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.
Media Release | December 3, 2012
A scientist at the University of British Columbia and Vancouver Coastal Health has identified the molecule that controls a scissor-like protein responsible for the production of plaques – the telltale sign of Alzheimer’s disease (AD).
Media Release | October 17, 2012
Multiple sclerosis (MS) patients sometimes experience “natural” improvements in disability at least over the short term, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.
Media Release | September 7, 2012
An international team led by a neurologist at the University of British Columbia and Vancouver Coastal Health has shown that a combination of aspirin and clopidogrel, both common blood thinners, does not prevent recurrence of a common type of stroke, and may even pose serious risks.
Widely prescribed MS treatment may not slow progression of disease: Vancouver Coastal Health and UBC Research
Media Release | July 17, 2012
Researchers with the UBC Hospital MS Clinic and Brain Research Centre at Vancouver Coastal Health and the University of British Columbia have published important data in the Journal of the American Medical Association (JAMA) about the impact of a common drug therapy on the progression of multiple sclerosis for people with the relapse-remitting form of the disease.
Media Release | July 3, 2012
Results from a clinical study by a UBC-Vancouver Coastal Health research team have increased hope for a new, effective and inexpensive anti-microbial treatment using inhalable nitric oxide.
Media Release | June 27, 2012
An international team led by human genetic researchers at the University of British Columbia and Vancouver Coastal Health has identified the latest gene associated with typical late-onset Lewy body Parkinson’s disease (PD), with the help of a Canadian Mennonite family of Dutch-German-Russian ancestry.
Media Release | June 21, 2012
Multiple sclerosis (MS) patients appear to have a lower cancer risk, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health. The […]
Preventing dementia: new research by VCH and UBC shows the trajectory of cognitive decline can be altered in seniors at risk for dementia
Media Release | April 23, 2012
Cognitive decline is a pressing global health care issue. Worldwide, one case of dementia is detected every seven seconds. Mild cognitive impairment is a well recognized risk factor for dementia, and represents a critical window of opportunity for intervening and altering the trajectory of cognitive decline in seniors.
Media Release | October 11, 2011
Representatives of the federal and provincial governments today marked the start of construction of a new centre at UBC that will unite brain research and patient care.
UBC-Vancouver Coastal Health researchers help discover common genetic cause of ALS and frontotemporal dementia
Media Release | September 21, 2011
A neuropathologist at University of British Columbia and Vancouver Coastal Health helped find a genetic abnormality that is the most common cause of two different but related forms of neurodegenerative disease: frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
Media Release | September 15, 2011
A group led by a University of British Columbia and Vancouver Coastal Health scientist has discovered a type of spinal cord cell that could function as a stem cell, with the ability to regenerate portions of the central nervous system in people with spinal cord injuries, multiple sclerosis or amyotrophic lateral sclerosis (Lou Gehrig’s disease).
Media Release | September 8, 2011
Less than two months after publishing findings about a new gene linked to late-onset Parkinson’s disease, the same team of scientists at the University of British Columbia and Vancouver Coastal Health Research Institute have discovered another gene responsible for the neurodegenerative disease – providing yet another target for potential treatments.
Media Release | August 30, 2011
The University of British Columbia today welcomed the appointment of Matthew Farrer as the new Dr. Donald Rix B.C. Leadership Chair in Genetic Medicine, the ninth B.C. Leadership Chair to be appointed at UBC.